	Ebitda		日
AbbVie	USD 3.69B	1.68B	2026-03
Amgen	USD 3.86B	1.28B	2026-03
Anika Therapeutics	USD 4.54M	3.67M	2025-12
Arrowhead Research	USD -147.68M	40.33M	2026-06
AstraZeneca	USD 5.16B	510M	2026-06
BioCryst Pharmaceuticals	USD 51.7M	30.14M	2025-09
Biogen	USD 649.7M	76.5M	2026-03
Bristol-Myers Squibb	USD 4.24B	1.37B	2026-03
Gilead Sciences	USD 3.51B	489M	2026-03
GlaxoSmithKline	GBP 3.51B	734M	2026-06
Halozyme Therapeutics	USD 328.81M	109.24M	2026-06
Heron Therapeutics	USD -3.88M	5.63M	2024-09
Immunic	USD -22.78M	753K	2024-06
Incyte	USD 778.57M	410.6M	2026-06
Insmed	USD -148.3M	165.88M	2026-03
Ionis Pharmaceuticals	USD -64.53M	135.49M	2026-03
J&J	USD 8.27B	1.08B	2026-03
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
Ligand Pharmaceuticals	USD -14.3M	81.08M	2026-03
Merck	USD -1.54B	7.84B	2026-03
Neurocrine Biosciences	USD 193.3M	25.1M	2026-03
Novartis	USD 6.48B	1.19B	2026-06
Novavax	USD 19.36M	190.79M	2025-12
Pfizer	USD 6.01B	18M	2026-06
PTC Therapeutics	USD 61.98M	132.97M	2026-03
Roche Holding	CHF 13.43B	744M	2026-06
Sarepta Therapeutics	USD 375.48M	627.68M	2026-03
Vertex Pharmaceuticals	USD 1.33B	130.5M	2026-06